Asymmetric septal hypertrophy in heterozygous cMyBP-C null mice.

[1]  L. Carrier,et al.  Effect of MyBP-C Binding to Actin on Contractility in Heart Muscle , 2003, The Journal of general physiology.

[2]  K. Schwartz,et al.  Biomolecular interactions between human recombinant beta-MyHC and cMyBP-Cs implicated in familial hypertrophic cardiomyopathy. , 2003, Cardiovascular research.

[3]  D. Gadsby,et al.  Paul F. Cranefield, M.D., Ph.D. April 28, 1925 to May 31, 2003 , 2003, The Journal of General Physiology.

[4]  M. Komajda,et al.  Hypertrophic Cardiomyopathy: Distribution of Disease Genes, Spectrum of Mutations, and Implications for a Molecular Diagnosis Strategy , 2003, Circulation.

[5]  H. Watkins.  Genetic clues to disease pathways in hypertrophic and dilated cardiomyopathies. , 2003, Circulation.

[6]  T. Marwick,et al.  Influence of wall stress and left ventricular geometry on the accuracy of dobutamine stress echocardiography. , 2002, Journal of the American College of Cardiology.

[7]  K. McDonald,et al.  Hypertrophic Cardiomyopathy in Cardiac Myosin Binding Protein-C Knockout Mice , 2002, Circulation research.

[8]  B. Maron.  Hypertrophic cardiomyopathy: a systematic review. , 2002, JAMA.

[9]  F J Schoen,et al.  Comparison of Two Murine Models of Familial Hypertrophic Cardiomyopathy , 2001, Circulation research.

[10]  J. Seidman,et al.  The Genetic Basis for Cardiomyopathy from Mutation Identification to Mechanistic Paradigms , 2001, Cell.

[11]  J. Daubert,et al.  Homozygotes for a R869G mutation in the beta -myosin heavy chain gene have a severe form of familial hypertrophic cardiomyopathy. , 2000, Journal of molecular and cellular cardiology.

[12]  M. Gautel,et al.  A newly created splice donor site in exon 25 of the MyBP-C gene is responsible for inherited hypertrophic cardiomyopathy with incomplete disease penetrance. , 2000, Circulation.

[13]  S. Winegrad.  Myosin binding protein C, a potential regulator of cardiac contractility. , 2000, Circulation research.

[14]  B. Hainque,et al.  COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes. , 1999, Journal of molecular biology.

[15]  D. Kass,et al.  Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice. , 1999, The Journal of clinical investigation.

[16]  T. Hewett,et al.  In vivo modeling of myosin binding protein C familial hypertrophic cardiomyopathy. , 1999, Circulation research.

[17]  M. Komajda,et al.  Double heterozygosity for mutations in the β-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy , 1999, Journal of medical genetics.

[18]  B. Hainque,et al.  Familial hypertrophic cardiomyopathy: from mutations to functional defects. , 1998, Circulation research.

[19]  D. Faxon.  AHA journals lead with definitive new online site. , 1998, Circulation research.

[20]  M. Gautel,et al.  Isoform transitions of the myosin binding protein C family in developing human and mouse muscles: lack of isoform transcomplementation in cardiac muscle. , 1998, Circulation research.

[21]  M. Fiszman,et al.  Cardiac myosin binding protein C gene is specifically expressed in heart during murine and human development. , 1998, Circulation research.

[22]  T. Mikawa,et al.  Isoform-specific Interaction of the Myosin-binding Proteins (MyBPs) with Skeletal and Cardiac Myosin Is a Property of the C-terminal Immunoglobulin Domain* , 1997, The Journal of Biological Chemistry.

[23]  W. Rottbauer,et al.  Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization Of cardiac transcript and protein. , 1997, The Journal of clinical investigation.

[24]  M. Komajda,et al.  Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy. , 1997, Circulation research.

[25]  Minoru Hongo,et al.  MLP-Deficient Mice Exhibit a Disruption of Cardiac Cytoarchitectural Organization, Dilated Cardiomyopathy, and Heart Failure , 1997, Cell.

[26]  R. Walsh,et al.  In vivo determination of left ventricular wall stress-shortening relationship in normal mice. , 1997, The American journal of physiology.

[27]  J. Ross,et al.  Transthoracic echocardiography in models of cardiac disease in the mouse. , 1996, Circulation.

[28]  Frederick J. Schoen,et al.  A Mouse Model of Familial Hypertrophic Cardiomyopathy , 1996, Science.

[29]  B Maisch,et al.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. , 1996, Circulation.

[30]  J. Seidman,et al.  Mutations in the cardiac myosin binding protein–C gene on chromosome 11 cause familial hypertrophic cardiomyopathy , 1995, Nature Genetics.

[31]  J. Beckmann,et al.  Cardiac myosin binding protein–C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy , 1995, Nature Genetics.

[32]  M. Burch,et al.  Hypertrophic cardiomyopathy. , 1994, Archives of disease in childhood.

[33]  R. Bronson,et al.  Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene , 1991, Cell.

[34]  G. Reeder.  Heart Disease: A Textbook of Cardiovascular Medicine , 1984 .

[35]  D. Garcia-Dorado,et al.  Cardiovascular Research , 1966 .

[36]  F J Schoen,et al.  Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the alpha cardiac myosin heavy chain gene. , 1999, The Journal of clinical investigation.

[37]  M. Gautel,et al.  A molecular map of the interactions between titin and myosin-binding protein C. Implications for sarcomeric assembly in familial hypertrophic cardiomyopathy. , 1996, European journal of biochemistry.